- FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines (4/18/23)
- FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use (4/13/23)
- HIVinfo: Updates to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (4/11/23)
- CEI: NYS Medical Providers—2023 CEI Annual Survey (4/11/23)
- FDA Approves First Over-the-Counter Naloxone Nasal Spray (3/29/23)
- NYSDOH AI & NYCDOHMH Mpox Dear Colleague Letter Announcing Spring and Summer Media Campaign (3/27/23)
- HIVinfo: Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (3/23/23)
- FDA Authorizes Bivalent Pfizer-BioNTech COVID-19 Vaccine as Booster Dose for Certain Children 6 Months through 4 Years of Age (3/14/23)
- CDC HAN: Increase in Extensively Drug-Resistant Shigellosis in the United States (3/2/23)
- FDA Authorizes First Over-the-Counter At-Home Test to Detect Both Influenza and COVID-19 Viruses (2/27/23)